Rankings
▼
Calendar
CRBU Q3 2020 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CRBU
Caribou Biosciences, Inc.
$181M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$1M
100.0% margin
Operating Income
-$8M
-686.9% margin
Net Income
-$8M
-662.2% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
-85.9%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$248,000
← FY 2020
All Quarters
Q4 2020 →